Objective: The aim of the study was to investigate the potential absorption of intratympanic ciprofloxacin through the human round window membrane.
Study Design: A prospective study.
Methods: Ciprofloxacin was instilled into the middle ear of 10 patients undergoing acoustic tumor removal. The lateral semicircular canal and vestibule were subsequently opened and, using a microsyringe, labyrinthine fluid was aspirated. A sample each of serum and cerebrospinal fluid was also drawn.
Results: Into each middle ear, 0.5 mL ciprofloxacin (0.3%) was instilled. The time interval between the ciprofloxacin application to the round window membrane and sampling of labyrinthine fluid and plasma ranged from 9 to 120 minutes. There was no measurable ciprofloxacin in the labyrinthine fluid, cerebrospinal fluid, or serum of 10 patients.
Conclusion: The lack of measurable absorption of intratympanic ciprofloxacin into the inner ear indicates that the chance of ototoxicity when ciprofloxacin is used clinically, even in the presence of a tympanic membrane perforation, is low.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00005537-200204000-00017 | DOI Listing |
Int J Pediatr Otorhinolaryngol
October 2023
Department of Otolaryngology - Head and Neck Surgery, McGill University, Montreal Children's Hospital, 1001 Decarie Blvd, Montreal, Quebec, H4A 3J1, Canada; McGill Otolaryngology Sciences Laboratory, Department of Pediatric Surgery, McGill University, McGill University Health Center, Canada. Electronic address:
Objective: N-acetylcysteine (NAC) is an anti-oxidant and mucolytic effective against bacterial biofilms, making it useful in the treatment of chronically discharging ears that are unresponsive to traditional treatment methods. The objective of this study was to evaluate the otologic safety of intratympanic NAC combined with Ciprodex® in an animal model.
Methods: Baseline distortion product otoacoustic emissions (DPOAE) and auditory brainstem response (ABR) measurements were performed for both ears on thirteen guinea pigs from the animal care research facilities of the McGill University Health Center.
PLoS One
December 2020
Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States of America.
Acute otitis media (AOM) is the main indication for pediatric antibiotic prescriptions, accounting for 25% of prescriptions. While the use of topical drops can minimize the administered dose of antibiotic and adverse systemic effects compared to oral antibiotics, their use has limitations, partially due to low patient compliance, high dosing frequency, and difficulty of administration. Lack of proper treatment can lead to development of chronic OM, which may require invasive interventions.
View Article and Find Full Text PDFJCI Insight
October 2018
Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, Boston Massachusetts, USA.
Otits media (OM) is the most frequent indication for antimicrobial prescription to US children. Streptococcus pneumoniae (S. pneumoniae) remains one of the most common pathogens causing OM.
View Article and Find Full Text PDFAm J Otolaryngol
September 2018
Department of Otolaryngology, Children's Hospital Colorado, 13123 East 16th Avenue, B455, Aurora, CO 80045, United States. Electronic address:
Purpose: Otorrhea frequently follows tympanostomy tube (TT) placement. We evaluated otorrhea following single 6mg OTO-201 (OTIPRIO®, ciprofloxacin otic suspension 6%) intraoperative injection into each middle ear in a variety of effusion types and concurrent procedures in children undergoing TT placement.
Secondary Objective: Efficacy based on Medicaid status and safety.
Otolaryngol Head Neck Surg
August 2016
Otonomy, Inc, San Diego, California, USA.
Objective: To investigate the efficacy, safety, and microbiology of a thermosensitive otic suspension of ciprofloxacin (OTO-201) in children with bilateral middle ear effusion undergoing tympanostomy tube placement.
Study Design: Two randomized, double-blind, sham-controlled phase 3 trials. Patients were randomized to intratympanic OTO-201 or sham.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!